glp-1+nad GLP-1 and NAD+ GLP1 receptor agonists are looking

During diabetes progression, the brains reliance on mitochondria makes it more vulnerable to oxidative damage compared to other regions

However, insights from cardiovascular and kidney outcome trials in individuals with T2D have shifted current guidelines toward a disease-modification approach

[15] [16] The scientific evidence examining the relationship between GLP-1 receptor agonists and suicidal ideation remains limited but largely reassuring

Without dose-finding studies, this remains guesswork

- Video Overview A study published in the journal The BMJ found no significant increase in thyroid cancer risk for people with type 2 diabetes on GLP-1 agonists compared with people treated with DPP4 inhibitors